IHAM
IVA

Integral Health Asset Management’s Inventiva IVA Stock Holding History

Integral Health Asset Management’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
+400,000
New +$2.44M 0.11% 88

Other funds holding IVA

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Integral Health Asset Management's IVA Position: Q1 2026 in Review

Integral Health Asset Management opened a new position in Inventiva (IVA) in Q1 2026: 400,000 shares worth $2.22M. The stake represents 0.11% of the portfolio and ranks #88 among its holdings.

65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

  • Integral Health Asset Management held 400,000 shares of Inventiva worth $2.22M as of Q1 2026.
  • Inventiva was a new Integral Health Asset Management position in Q1 2026.
  • Inventiva made up 0.11% of Integral Health Asset Management's portfolio in Q1 2026, its #88 holding.
  • 65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.